CureVac N.V. Profit Margin

CureVac N.V. (CVAC) currently reports a profit margin of 37.93% as of November 2025. That compares with 20.29% in the prior-year period — up 86.9% year over year. That is above the Healthcare sector average of 15.58%. Use the charts on this page to explore CureVac N.V.'s profit margin history and peer comparisons.

CureVac N.V.'s profit margin increased from 20.29% to 37.93% — a 86.9% year-over-year increase (period ending November 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CureVac N.V.'s profit margin of 37.93% is higher than the Healthcare sector average of 15.58%. That is roughly 143.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but CureVac N.V.'s current 37.93% should be judged against Healthcare norms (sector average: 15.58%) and against CVAC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 37.93%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for CureVac N.V., and consider following CVAC for alerts when major investors trade the stock.